“ Egypt is a place where it takes longer to do business, there are hurdles because we have a huge administration and bureaucracy, but it is worth… ”
In Conversation
“ Even though we are a mid-sized company, and the competition is tough, we are working very hard to achieve success [in oncology] ”
“ Immuno-oncology has revolutionized cancer therapy, but despite the huge success there has been in the area, there are still many unmet patient needs ”
“ Our preclinical data and clinical experience with our pipelines have been highly promising, and we are eager to advance our clinical trials to later stages. ”
“ UCB has a firm commitment to innovation as evidenced by the fact that it invests 28% of its turnover in R&D. ”
“ We are the shining star in the Middle East, with a strategic location, fantastic connectivity, effective governance and regulations – we expect these qualities to attract… ”
“ [In the National Recovery and Resilience Plan] AGENAS is ... the point of connection between the Ministry of Health and the regions [and] EUR 15.63 billion… ”
“ Since the Organon spinoff, the strategy to focus on specific parts of the portfolio is clearer than ever. We are fully committed to working on three… ”
“ ... price erosion is such a big concern in the Spanish market ... The pricing system for generics is forcing both brands and generics to compete… ”
“ We are one of the few companies focusing heavily on pain. There are not many ... because is not an easy area in which to bring… ”
“ ... the difference between IBSA and other companies is that we have both pharma and medical devices ... We develop and patent new technologies to deliver… ”
“ ... the decision to combine our capabilities in the US allowed Stevanato Group to reach an agreement with the Biomedical Advanced Research and Development Authority (BARDA)… ”
